Integra Lifesciences (IART) 86.78 $IART Integra

New Post Public Reply Private Reply Replies (0) Message Board

Sep 1, 2016 at 7:05 PM

Integra Lifesciences (IART) 86.78 $IART

Integra LifeSciences Has Returned 47.4% Since SmarTrend Recommendation (IART)
Comtex SmarTrend(R) - Mon Aug 29, 12:52PM CDT
SmarTrend identified an Uptrend for Integra LifeSciences (NASDAQ:IART) on February 22nd, 2016 at $58.86. In approximately 6 months, Integra LifeSciences has returned 47.38% as of today's recent price of $86.74.
IART: 86.78 (+0.36)

Integra LifeSciences to Present at the Wells Fargo 2016 Healthcare Conference and the Morgan Stanley Global Healthcare Conference in September 2016
GlobeNewswire - Mon Aug 22, 3:05PM CDT
Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it will present at the following conferences in September:
IART: 86.78 (+0.36), IARTV: 65.00 (-37.45), WFC: 50.43 (-0.37), MS: 31.91 (-0.15)

44.9% Return Seen to Date on SmarTrend Integra LifeSciences Call (IART)
Comtex SmarTrend(R) - Fri Aug 19, 12:52PM CDT
SmarTrend identified an Uptrend for Integra LifeSciences (NASDAQ:IART) on February 22nd, 2016 at $58.86. In approximately 6 months, Integra LifeSciences has returned 44.93% as of today's recent price of $85.30.
IART: 86.78 (+0.36)

Uptrend Call Working As Integra LifeSciences Stock Rises 42.6% (IART)
Comtex SmarTrend(R) - Fri Aug 12, 12:25AM CDT
SmarTrend identified an Uptrend for Integra LifeSciences (NASDAQ:IART) on February 22nd, 2016 at $58.86. In approximately 6 months, Integra LifeSciences has returned 42.55% as of today's recent price of $83.90.
IART: 86.78 (+0.36)

Integra (IART) Tops Q2 Earnings, Grows Organically, Ups View
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 3:05PM CDT
Integra LifeSciences Holdings Corporation (IART) reported adjusted earnings per share (EPS) of 79 cents in the second quarter of 2016.
IART: 86.78 (+0.36), FCSC: 0.90 (-0.06), ANIP: 61.42 (+1.68), ANIK: 47.94 (+0.70)

Integra LifeSciences Announces that Omnigraft(TM) Dermal Regeneration Matrix was Recognized as a Top Ten Innovation by Podiatry Today
GlobeNewswire - Mon Aug 01, 7:30AM CDT
Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that its recently introduced product, Integra(R) Omnigraft(TM) Dermal Regeneration Matrix, has been recognized by Podiatry Today as one of the "Top Ten Innovations in Podiatry" in 2016. Podiatry Today is an award-winning, premier publication that emphasizes informative clinical features and practice management articles. Annually, Podiatry Today picks the most innovative products in the podiatric industry to showcase in their monthly publication.
IART: 86.78 (+0.36), IARTV: 65.00 (-37.45)

Integra LifeSciences Reports Second Quarter 2016 Financial Results
GlobeNewswire - Thu Jul 28, 5:00AM CDT
Revenue Increased 17.2% to $249.3 million; Organic Revenue Increased 10.7%
IART: 86.78 (+0.36)

Shares of IART Up 34.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jul 28, 12:36AM CDT
SmarTrend identified an Uptrend for Integra LifeSciences (NASDAQ:IART) on February 22nd, 2016 at $58.86. In approximately 5 months, Integra LifeSciences has returned 34.11% as of today's recent price of $78.93.
IART: 86.78 (+0.36)

Integra LifeSciences Has Returned 30.3% Since SmarTrend Recommendation (IART)
Comtex SmarTrend(R) - Mon Jun 20, 1:06PM CDT
SmarTrend identified an Uptrend for Integra LifeSciences (NASDAQ:IART) on February 22nd, 2016 at $58.86. In approximately 4 months, Integra LifeSciences has returned 30.30% as of today's recent price of $76.69.
IART: 86.78 (+0.36)

29.5% Return Seen to Date on SmarTrend Integra LifeSciences Call (IART)
Comtex SmarTrend(R) - Fri Jun 10, 1:07PM CDT
SmarTrend identified an Uptrend for Integra LifeSciences (NASDAQ:IART) on February 22nd, 2016 at $58.86. In approximately 4 months, Integra LifeSciences has returned 29.50% as of today's recent price of $76.22.
IART: 86.78 (+0.36)

Integra (IART): Strong Revenue Growth on Global Prospects
Zacks Equity Research - Zacks Investment Research - Wed Jun 01, 7:16AM CDT
On May 31, 2016, we issued an updated research report on Plainsboro, NJ-based Integra LifeSciences Holdings Corporation (IART).
IART: 86.78 (+0.36), ANIP: 61.42 (+1.68), NEO: 7.95 (-0.09), RTRX: 16.35 (+0.33)

Integra LifeSciences Has Returned 23.6% Since SmarTrend Recommendation (IART)
Comtex SmarTrend(R) - Thu May 26, 1:24PM CDT
SmarTrend identified an Uptrend for Integra LifeSciences (NASDAQ:IART) on February 22nd, 2016 at $58.86. In approximately 3 months, Integra LifeSciences has returned 23.61% as of today's recent price of $72.75.
IART: 86.78 (+0.36)

Integra LifeSciences to Present at the Jefferies 2016 Healthcare Conference in June 2016
GlobeNewswire - Wed May 25, 3:05PM CDT
Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it will present at the following conferences in June:
IART: 86.78 (+0.36), IARTV: 65.00 (-37.45)

Integra Unveils Fin-Lock Glenoid, Boosts Shoulder Arthroplasty
Zacks Equity Research - Zacks Investment Research - Tue May 24, 7:22AM CDT
Integra LifeSciences Holdings Corporation (IART) recently launched Integra Fin-Lock Glenoid.
IART: 86.78 (+0.36), HSKA: 52.76 (-1.81), ANIP: 61.42 (+1.68), NEO: 7.95 (-0.09)

Integra LifeSciences launches Integra(R) Fin-Lock(TM) Glenoid for the Titan(TM) Modular Shoulder System
GlobeNewswire - Mon May 23, 7:30AM CDT
Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced the launch of the Integra(R) Fin-Lock(TM) Glenoid. This addition to the Titan(TM) Modular Shoulder System increases the glenoid offerings to include features intended to help maximize long-term fixation and implant longevity.
IART: 86.78 (+0.36), IARTV: 65.00 (-37.45)

Integra LifeSciences Receives FDA Approval for Integra(R) Omnigraft(TM) Dermal Regeneration Matrix, Clearing the Way for Commercial Release
GlobeNewswire - Wed May 11, 7:30AM CDT
Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that the Company has received approval from the U.S. Food and Drug Administration (FDA) for the packaging of its new product, Integra(R) Omnigraft(TM) Dermal Regeneration Matrix, which clears the way for its commercial release. The product's unique packaging is designed for ease of handling and application in the outpatient wound care setting.
IART: 86.78 (+0.36), IARTV: 65.00 (-37.45)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

OSHA and NSC Forge Alliance to Prevent Worksite Tragedies

Forging Ahead With a Crucial Collaboration Ins, outs, ups, and downs—safety shouldn’t get lost in the shuffle, but it does. In steps the National Serious Injury and Fatality Prevention Alliance, a fresh partnership convened by OSHA with the National Safety Council—hop on board or get left behind mindsets. We’re talking about real, heads-down, hard-hitting actions...

Roof Replacement Timelines: Key Insights for PA Homeowners

There's no denying it; having a roof over your head is one thing, but knowing when to replace it is a whole other ballgame. In Pennsylvania, where the weather loves to throw curveballs, making the right call on roof replacement can save a heap of trouble down the road. Thanks to Miguel Cornejo and his insights in HelloNation’s latest rundown, we get a clearer picture of...

EPR Fireworks, Schedule2.IT Enhance EMS Integration

Joining Forces for Effective EMS Management In a move that could shake up emergency medical services, EPR Fireworks has teamed up with Schedule2.IT to amp up integration. This Florida-based partnership is all about breaking down those bureaucratic firewalls between patient care and controlled substances tracking. They’re pushing for a seamless workflow, where crucial...

JennAir and Cosentino Introduce Seamless Kitchen Aesthetics

It's not every day that the kitchen landscape gets a bold makeover, but JennAir and Cosentino seem to think it's time. Introducing their latest splash, the JennAir x Dekton panel collection is here to redefine what luxury kitchens can look like—an embodiment of seamless beauty that’s more sculpture than cooking space. Elevating Kitchen Design So, what's the buzz about...

Local Expertise in Real Estate: Key to Success?

Local Market Know-How: A Seller's Best Asset So you're thinking about selling your home in North Carolina, huh? Here's a tip—get yourself a local real estate pro who knows the ins and outs of your neighborhood like the back of their hand. Michael McCollum, a prominent voice from Reidsville, NC, highlights how crucial local expertise can be in navigating the widely...

Vortex Expands UK Reach with Torrent Acquisition Boost

Vortex's Ambitious UK Expansion A seasoned investor keen on infrastructure plays would find Vortex Companies’ latest move significant—not just another acquisition, but a realigned strategy for dominance as Britain braces for an infrastructure overhaul. With Torrent Drainage Services in their pocket, the Vortex Group plans to amp up its trenchless rehabilitation...

Superga and Pasqua's Unlikely Fashion-Vineyard Fusion

Superga and Pasqua: A Fusion of Fashion and Vineyards Here's one for the books: Superga, the storied Italian footwear maestro, teaming up with Pasqua Wines, straight out of Verona’s vineyard heartland. On the surface, it seems a rather odd coupling. One's got rubber soles; the other’s got corks. But they’ve pulled off a daring bedroom switch, creating a...

Crucial Insights for South GA Home Insurance Choices

Understanding the Insurance Jargon Here we go again, dealing with insurance gobbledygook that’s about as clear as mud to most of us. Homeowners in South Georgia are being urged to pay attention to the differences between replacement cost and actual cash value in their insurance policies. This ain't just legalese, folks—it's your protection when disaster strikes in our...

Medicare Payment Proposal Faces Doctor Backlash in D.C.

Why Same-Day Medicare Care Matters Imagine you're gasping for breath, struggling to find relief, and then being told to wait weeks for care. It's not just an inconvenience; it's a health hazard. This isn't some arbitrary tale—it's the gritty reality for folks relying on same-day care. A group of docs and advocates recently stormed Capitol Hill sounding the alarm about a...

FSS Unveils AI Tool to Simplify Bankruptcy Cases

AI Revolution in Bankruptcy Management Alright, folks, there's a fresh breeze blowing in the bankruptcy management world, and it bears the acronym FSS. Financial Software Solutions is rolling out its innovative FSS Intelligence Engine. This little powerhouse aims to turn what used to be a gut-wrenching slog through mountains of paperwork into a slick, automated process....